Literature DB >> 14378628

Activity of piperazine, in vitro, against Ascaris lumbricoides.

O D STANDEN.   

Abstract

Entities:  

Keywords:  ASCARIS; PIPERAZINES/effects

Mesh：

Substances：

Year:  1955        PMID： 14378628      PMCID： PMC1980175          DOI： 10.1136/bmj.2.4930.20-a

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  3 in total

1.  Treatment of Ascaris lumbricoides infections with piperazine citrate.

Authors:  H W BROWN; M M STERMAN
Journal:  Am J Trop Med Hyg       Date:  1954-07       Impact factor: 2.345

2.  Ascariasis treated with piperazine hydrate.

Authors:  R H WHITE
Journal:  Lancet       Date:  1954-08-14       Impact factor: 79.321

3.  [Conditions of life of the swine ascaris, Ascaris lumbricoides Linnaeus outside the host organism].

Authors:  R CAVIER; J SAVEL
Journal:  C R Hebd Seances Acad Sci       Date:  1952-03-10
  3 in total
  5 in total

1.  Effect of piperazine on the level of phospholipids and on the activities of certain enzymes of phospholipid metabolism in human Ascaris lumbricoides.

Authors:  P K Sasi; R Kaleysa Raj
Journal:  Experientia       Date:  1975-11-15

2.  The pharmacology of the cholinoceptor in muscle preparations of Ascaris lumbricoides var. suum.

Authors:  I L Natoff
Journal:  Br J Pharmacol       Date:  1969-09       Impact factor: 8.739

3.  A method for recording the effects of anthelmintics on the movements of Ascaris lumbricoides.

Authors:  L G GOODWIN
Journal:  Br J Pharmacol Chemother       Date:  1958-06

4.  MECHANISM OF THE PARALYSING ACTION OF PIPERAZINE ON ASCARIS MUSCLE.

Authors:  J DELCASTILLO; W C DEMELLO; T MORALES
Journal:  Br J Pharmacol Chemother       Date:  1964-06

5.  Hydroxyethylamine Based Phthalimides as New Class of Plasmepsin Hits: Design, Synthesis and Antimalarial Evaluation.

Authors:  Anil K Singh; Sumit Rathore; Yan Tang; Nathan E Goldfarb; Ben M Dunn; Vinoth Rajendran; Prahlad C Ghosh; Neelu Singh; N Latha; Brajendra K Singh; Manmeet Rawat; Brijesh Rathi
Journal:  PLoS One       Date:  2015-10-26       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.